Condition
Penile Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 14 Penile Cancer clinical trials that are recruiting, at sites in 7 countries (most in China (7), United States (3), Norway (1)). By phase: Phase 2 (7), Phase 1 (2), Phase 1/2 (1). The most active sponsors are Fudan University (3), Rutgers, The State University of New Jersey (2), West China Hospital (2). There are also 1 NIH-funded research project on Penile Cancer, with $427,249 in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 14Clinical trials
- 1NIH research projects
- 7Countries
Newest Penile Cancer clinical trials
All recruiting trials (14)
-
EGFR-targeted therapy plus PD-1 blocker before surgery for advanced penile cancer
This phase II trial tests whether Becotatug vedotin plus Pucotenlimab given before surgery can shrink tumors in men with advanced penile cancer and help preserve the penis when possible.
-
Beocotatug Vedotin plus Pucotenlimab for EGFR-positive advanced penile cancer
This trial tests whether a targeted antibody-drug conjugate plus a PD-1 inhibitor can help people with EGFR-positive advanced penile cancer who have limited or no chemotherapy options.
-
QL1706 with lenvatinib for previously treated penile cancer
This trial tests whether combining QL1706 with lenvatinib can help control advanced or metastatic penile squamous cell carcinoma in people whose disease progressed after prior treatments.
-
Comparing open and robot-assisted removal of groin lymph nodes for penile cancer
This trial will test whether robot-assisted groin lymph node removal causes fewer complications and faster recovery than standard open surgery for men with penile squamous cell carcinoma who need lymphadenectomy.
-
MRG003 plus HX008 for EGFR-positive advanced or metastatic penile squamous cell carcinoma
This trial tests whether combining the EGFR-targeted antibody-drug conjugate MRG003 with the PD-1 inhibitor HX008 works as a first-line treatment for men with EGFR-positive advanced or metastatic penile cancer.
-
Treatment of rare advanced tumors with a combination of drugs
This study is testing a new combination of drugs to see if it can help people with rare advanced tumors live longer and feel better.
-
Using Ivocizumab to treat various advanced rare tumors
This study is testing if a new treatment called Ivocizumab can help people with different types of advanced rare tumors feel better and live longer.
-
Using SCG142 TCR-T cells to treat HPV-related cancers
This study is testing a new type of immune cell treatment called SCG142 TCR-T cells to see if it can help people with advanced cancers related to HPV.
-
Combination of chemotherapy and immunotherapy for advanced penile cancer
This study is testing a new treatment combining chemotherapy and immunotherapy for adults with advanced penile cancer to see if it helps them respond better to therapy and manage their disease.
-
Immunotherapy using E7 TCR-T cells for HPV-related cancers
This study is testing a new immunotherapy using E7 TCR-T cells to see if it can help people with advanced HPV-related cancers like cervical and throat cancer feel better and improve their health.
-
E7 T-cell therapy for advanced HPV-related cancers
This study is testing a new treatment using specially modified immune cells to see if it can help people with advanced cancers linked to HPV feel better and live longer.
-
Using MRI to assess penile cancer before surgery
This study is testing whether a special type of MRI can help doctors better plan surgery for men with newly diagnosed penile cancer to improve their quality of life and reduce the chance of the cancer coming back.
-
Understanding lymphedema after urologic surgery
This study looks at how often and how badly lymphedema affects people after they have surgery for urologic cancer that involves removing lymph nodes.
-
A resource for collecting cancer data and biospecimens
This study is creating a resource to collect health information and samples from cancer patients and healthy individuals to help improve cancer prevention and treatment strategies.
NIH-funded research (1)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Understanding how the penile cancer microbiome and p16 relate to HPV and outcomes across diverse patients
This project will look at how the tiny microbes living in penile tumors, p16 protein levels, high-risk HPV, and clinical outcomes are connected across patients from different regions.
Related topics
Quick answers
How many Penile Cancer clinical trials are recruiting right now?
14, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in China (7 trials), United States (3 trials), Norway (1 trial), Germany (1 trial), Sweden (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 7, Phase 1: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.